“We created the platform to provide new information to drug makers to help them better understand the amount of pain a certain injectable medication may cause a patient,” Han said. “They can then work to design and optimize the drug formulations or injection devices to minimize the pain associated with injection.”
“These data demonstrate the therapeutic benefit of blocking Vegfa/Nrp1 interaction in the treatment of psoriatic disease, which may be safer for the treatment of psoriasis as compared to other therapeutic modalities that can be associated with serious side effects,” said Dr. Cédric Blanpain, the senior author of this study.
“Our research has a direct impact on treatment management. In patients with M. pneumoniae infections, symptoms may be improved not only through treatment with antibiotics, but also with drugs that modulate the possibly disease-causing immune response,” said Dr. Patrick Meyer Sauteur.
Registration has opened for the 2020 Skin Spectrum Summit. This is the fifth annual hosting of Canada's premier one-day educational congress of Dermatologists, General Practitioners, and Family Physicians. The Summit, its organizers and faculty are committed to providing better dermatologic care for the region's diverse and growing ethnic communities, notably those with Fitzpatrick Scale skin types I...